Thus, our correlate of protection based on the magnitude of pre-infection frequencies of vaccine-induced IFN-γ + CD4 + T cells is in line with previous studies, and indicates that CMV vector-mediated protection against influenza could be improved by refining the vaccine to optimize the priming of influenza-specific CD4 + T cells. This evidence concerns the gene CD4 and influenza.